Home > Drug Search >
  • company_query: Beijing Tri-Prime Genetic Engineering
  •   > 
Drug Filter
Category:
chemistry (2) biology (37)
Status:
Approved (4) Phase Ⅲ (7) Phase Ⅱ (22) Phase Ⅰ (5) IND Filing (1)
Clinical Stage:
Pending (1) Active (32) Discontinued (2)
Bio-Type:
Gene therapy (1) Cell therapy (1) Vaccine (7) Allergen extract (1) Microbial extract (1) Recombinant polypeptide (1) Recombinant coagulation factor (1) Recombinant cytokines (1) Recombinant hormone (1) Whole antibody (5) Fab fragment (2) ADC (1) Fusion protein (2)
Indication:
Non-alcoholic steatohepatitis (1) Acute myeloid Leukemia (AML) (1) Amyotrophic lateral sclerosis (ALS) (2) Breast cancer (2) Rectal cancer (1) Cystic fibrosis (CF) (1) Neuronal ceroid lipofuscinoses (1) Transplant rejection (1) Follicular lymphoma (1) Gastric cancer (1) Wet age-related macular degeneration (1) Cytomegalovirus infections (1) HBV infection (2) HCV infection (4) Alcoholic hepatitis (1) Hepatocellular carcinoma (HCC) (1) HIV infection (1) Timothy grass pollen-induced allergic rhinitis (1) Blepharospasm (1) Glabellar line (1) Somatotropin deficiency (1) Leukemia (1) Melanoma (1) Multiple myeloma (MM) (2) Multiple sclerosis (MS) (1) Myelodysplastic syndrome (MDS) (1) Non small cell lung cancer (NSCLC) (3) Osteoporosis (1) Overactive bladder (OAB) (1) Pancreatic cancer (3) Postherpetic neuralgia (PHN) (1) Prostate cancer (2) Rheumatoid arthritis (RA) (2) Solid tumours (5) Thyroid cancer (1) Germ cell and embryonal neoplasms (1) Colorectal cancer (3) Malignant glioma (1) Autistic disorder (1) B-cell lymphoma (1) Sickle cell disease (1) Neutropenia (2) Renal carcinoma (1) Progressive supranuclear palsy (1) Glioma (3) Diffuse large B cell lymphoma (2) Blood coagulation disorders (1) Hemophilia (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top